KEYWORD INDEX

Click on the first letter of the keyword:
 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Search results for: "L"
Results 1 - 10 of 101 shown below
L-5-HTP
Herbert Meltzer, Bijan Bastani, Karuna Jayathilake and Michael Maes
Fluoxetine, but not Tricyclic Antidepressants, Potentiates the 5-Hydroxytryptophan-Mediated Increase in Plasma Cortisol and Prolactin Secretion in Subjects with Major Depression or with Obsessive Compulsive Disorder
doi:10.1016/S0893-133X(96)00280-1
Neuropsychopharmacology 17, 1-11

Abstract | PDF |
L-745,870
Kehong Zhang, Christopher J Grady, Evangelia M Tsapakis, Susan L Andersen, Frank I Tarazi and Ross J Baldessarini
Regulation of Working Memory by Dopamine D4 Receptor in Rats
doi:10.1038/sj.npp.1300491
Neuropsychopharmacology 29, 1648-1655

Abstract | Full text | PDF |
Jeremiah J Clifford and John L Waddington
Topographically Based Search for an "Ethogram" Among a Series of Novel D4 Dopamine Receptor Agonists and Antagonists
doi:10.1016/S0893-133X(99)00141-4
Neuropsychopharmacology 22, 538-544

Abstract | Full text | PDF |
L-750,667
Sharon M Anderson, Heath D Schmidt and R Christopher Pierce
Administration of the D2 Dopamine Receptor Antagonist Sulpiride into the Shell, but not the Core, of the Nucleus Accumbens Attenuates Cocaine Priming-Induced Reinstatement of Drug Seeking
doi:10.1038/sj.npp.1300922
Neuropsychopharmacology 31, 1452-1461

Abstract | Full text | PDF |
L-dopa
Una D McCann, David Thorne, Martica Hall, Kathy Popp, Warren Avery, Helen Sing, Maria Thomas and Gregory Belenky
The Effects of L-Dihydroxyphenylalanine on Alertness and Mood in alpha-Methyl-Para-Tyrosine-Treated Healthy Humans
doi:10.1016/0893-133X(94)00134-L
Neuropsychopharmacology 13, 41-52

Abstract | PDF |
L-Thyroxine
Pradip Kumar Sarkar and Arun Kumar Ray
Synaptosomal T3 Content in Cerebral Cortex of Adult Rat in Different Thyroidal States
doi:10.1038/sj.npp.1380101
Neuropsychopharmacology 11, 151-155

Abstract | PDF |
Michael Bauer, Anne Berghöfer, Tom Bschor, Andreas Baumgartner, Ursula Kiesslinger, Rainer Hellweg, Mazda Adli, Christopher Baethge and Bruno Müller-Oerlinghausen
Supraphysiological Doses of L-Thyroxine in the Maintenance Treatment of Prophylaxis-Resistant Affective Disorders
doi:10.1016/S0893-133X(02)00320-2
Neuropsychopharmacology 27, 620-628

Abstract | Full text | PDF |
L-Triiodothyronine
Pradip Kumar Sarkar and Arun Kumar Ray
Synaptosomal T3 Content in Cerebral Cortex of Adult Rat in Different Thyroidal States
doi:10.1038/sj.npp.1380101
Neuropsychopharmacology 11, 151-155

Abstract | PDF |
L-tryptophan
Michael Maes, Annick Wauters, Robert Verkerk, Paul Demedts, Hugo Neels, Ann Van Gastel, Paul Cosyns, Simon Scharpé and Roger Desnyder
Lower Serum L-Tryptophan Availability in Depression as a Marker of a More Generalized Disorder in Protein Metabolism
doi:10.1016/0893-133X(95)00181-C
Neuropsychopharmacology 15, 243-251

Abstract | PDF |
Katherine P Weld, Joy A Mench, Ruth A Woodward, Monica S Bolesta, Stephen J Suomi and J Dee Higley
Effect of Tryptophan Treatment on Self-Biting and Central Nervous System Serotonin Metabolism in Rhesus Monkeys (Macaca mulatta)
doi:10.1038/sj.npp.1395210
Neuropsychopharmacology 19, 314-321

Abstract | Full text | PDF |
L-type calcium channel
Evegeny M Krupitsky, Andrey M Burakov, Tatyana N Romanova, Nina I Grinenko, Alexander Y Grinenko, Jason Fletcher, Ismene L Petrakis and John H Krystal
Attenuation of Ketamine Effects by Nimodipine Pretreatment in Recovering Ethanol Dependent Men: Psychopharmacologic Implications of the Interaction of NMDA and L-Type Calcium Channel Antagonists
doi:10.1016/S0893-133X(01)00346-3
Neuropsychopharmacology 25, 936-947

Abstract | Full text | PDF |
laboratory
David J Drobes, Raymond F Anton, Suzanne E Thomas and Konstantin Voronin
A Clinical Laboratory Paradigm for Evaluating Medication Effects on Alcohol Consumption: Naltrexone and Nalmefene
doi:10.1038/sj.npp.1300101
Neuropsychopharmacology 28, 755-764

Abstract | Full text | PDF |
laboratory experiment
Scott D Lane, Don R Cherek, Oleg V Tcheremissine, Lori M Lieving and Cythia J Pietras
Acute Marijuana Effects on Human Risk Taking
doi:10.1038/sj.npp.1300620
Neuropsychopharmacology 30, 800-809

Abstract | Full text | PDF |
Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | | Next next
  top go to top

Extra navigation

.
ADVERTISEMENT